Related Experiment Video
Updated: Jul 3, 2026

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex
Published on: August 2, 2021
MUC1 oncoprotein blocks death receptor-mediated apoptosis by inhibiting recruitment of caspase-8
Naoki Agata1, Rehan Ahmad, Takeshi Kawano
1Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
Abstract:
Stimulation of the death receptor superfamily induces the activation of caspase-8 and thereby the apoptotic response. The MUC1 oncoprotein is aberrantly overexpressed by diverse human malignancies and inhibits stress-induced apoptosis. The present results show that MUC1 blocks activation of caspase-8 and apoptosis in the response of malignant cells to tumor necrosis factor alpha, tumor necrosis factor-related apoptosis-inducing ligand, and Fas ligand. The results show that MUC1 associates constitutively with caspase-8. The MUC1 cytoplasmic domain (MUC1-CD) binds directly to the caspase-8 p18 fragment upstream to the catalytic Cys(360) site. The results also show that MUC1-CD binds to Fas-associated death domain (FADD) at the death effector domain. In nonmalignant epithelial cells, MUC1 interacts with caspase-8 and FADD as an induced response to death receptor stimulation. The functional significance of these interactions is supported by the demonstration that MUC1 competes with caspase-8 for binding to FADD and blocks recruitment of caspase-8 to the death-inducing signaling complex. These findings indicate that MUC1 is of importance to the physiologic regulation of caspase-8 activity and that overexpression of MUC1, as found in human malignancies, could contribute to constitutive inhibition of death receptor signaling pathways.
Insights
The MUC1 oncoprotein inhibits apoptosis by blocking caspase-8 activation in cancer cells. This interaction prevents the death receptor pathway, contributing to tumor survival.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The death receptor superfamily initiates apoptosis via caspase-8 activation.
- The MUC1 oncoprotein is overexpressed in many cancers and inhibits apoptosis.
- Understanding MUC1's role in apoptosis is crucial for cancer therapy.
Purpose of the Study:
- To investigate the mechanism by which MUC1 inhibits apoptosis.
- To determine MUC1's interaction with caspase-8 and related signaling molecules.
- To elucidate MUC1's role in regulating death receptor signaling in malignancies.
Main Methods:
- Co-immunoprecipitation assays to study protein interactions.
- Analysis of caspase-8 activation and apoptotic response.
- In vitro binding assays using MUC1 cytoplasmic domain (MUC1-CD) and FADD.
Main Results:
- MUC1 constitutively associates with caspase-8 in malignant cells.
- MUC1-CD directly binds to caspase-8 and Fas-associated death domain (FADD).
- MUC1 blocks caspase-8 recruitment to the death-inducing signaling complex, inhibiting apoptosis.
Conclusions:
- MUC1 inhibits apoptosis by preventing caspase-8 activation through direct interaction with caspase-8 and FADD.
- MUC1's overexpression in cancer contributes to the constitutive inhibition of death receptor signaling.
- Targeting MUC1 interaction with caspase-8 may offer a therapeutic strategy for overcoming apoptosis resistance in cancer.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Caspases
The Intrinsic Apoptotic Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Abnormal Proliferation
Apoptosis

